American Heart Association (AHA) | European Society of Cardiology (ESC) | |
Adult dose | Pediatric dose | Adult dose |
Daptomycin¶ 10 to 12 mg/kg IV every 24 hours for >6 weeks or LinezolidΔ 600 mg IV or orally every 12 hours for >6 weeks | Consultation with a pediatric infectious disease specialist is recommended | Daptomycin 10 to 12 mg/kg per 24 hours IV once daily for ≥8 weeks plus one of the following Ampicillin 300 mg/kg per 24 hours IV in 4 to 6 divided doses for ≥8 weeks or Ertapenem 2 g IV once daily or Ceftaroline 1800 mg/day IV in 3 divided doses or Fosfomycin 12 g/day IV in 4 divided doses |
ESC: European Society of Cardiology; HLAR: high-level aminoglycoside resistance; IV: intravenously; MIC: minimum inhibitory concentration.
* Patients with endocarditis caused by these strains, most commonly Enterococcus faecium, should be treated in consultation with an infectious disease specialist; cardiac valve replacement may be necessary for bacteriologic cure; cure with antimicrobial therapy alone may be <50%.
¶ Our approach is in alignment with the ESC; we favor treatment with daptomycin, in combination with an additional agent such as ampicillin, ertapenem, or ceftaroline.
Δ Linezolid use may be associated with potentially severe bone marrow suppression, neuropathy, and drug interactions. Monitor hematologic toxicity.